Editing Scientists

=== Anti-Tobacco Advocates & Researchers ===
[* ''Denotes documented RWJF funding'']

'''RWJF''': Robert Wood Johnson Foundation. The Robert Wood Johnson Foundation is the biggest single shareholder in Nicotine Replacement Therapy (NRT) producer Johnson&Johnson and began its massive funding of tobacco control in the U.S. in 1991, the same year the FDA approved the nicotine patch as a prescription drug.
*'''Ahluwalia, Jasjit'''*
:Dept of Preventive Medicine and Dept. of Internal Medicine, School of Medicine, University of Kansas, Kansas City. RWJF Generalist Physician Faculty Scholars Award and recipient of honoraria and grant support from Glaxo Wellcome (makers of Zyban), SmithKline Beecham (makers of Nicorette and Nicoderm) AND Johnson & Johnson’s McNeil Consumer Products (makers of Nicotrol and other cessation products).  Chair of Nominations Committee for Society for Research on Nicotine and Tobacco [SRNT].
*'''Altman, David'''*
:At Bowman Grey School of Medicine, Department of Public Health in Winston-Salem, NC.  Served as a consultant and helped administer RWJF’s “Tobacco Policy Research & Evaluation Program.”
*'''Arno, Peter S.'''*
:Associate Professor, Dept. of Epidemiology and Social Medicine, Montefiore Medical Center in the Bronx.  Listed in RWJF’s media guide for “Ethical, social and Public Health Implications of Regulating Tobacco,” which was a “study” of the tobacco industry’s influence in weakening anti-tobacco legislation and litigation (and even the 60 Minutes Wigand show).  Arno’s study blames tobacco industry campaign funding.
*'''Benowitz, Neal'''
:Prof. of medicine, UC San Francisco. A reviewer for Tobacco Control. A member discussion group chair for Society for Research on Nicotine and Tobacco [SRNT].
*'''Bero, Lisa'''*
:Assistant Professor, Institute for Health Policy Studies, UC San Francisco. A colleague of and sometimes co-publisher with Stanton Glantz.  Listed in RWJF media guide for “Quality of Research on Environmental Tobacco Smoke by Different Sponsors.”
:Bero has been given substantial RWJF money for this project, the results of which were published in JAMA in l999. Basically the “study” says any studies conducted with tobacco funding are bad, but those conducted with other funding (ostensibly including pharmaceutical money from RWJF) are good.  A reviewer for Tobacco Control.
*'''Biener, Lois'''*
:Senior Research Fellow, University of Massachusetts at Boston Center for Survey Research, Boston MA.  Listed as a media contact in RWJF’s guide for “Survey on Responses to the Massachusetts Tobacco Control Program.”  The survey would, among other things, “determine the characteristics of smokers who are most responsive to media messages and to determine which segments of the population are most likely to adopt anti-tobacco stances.” Biener received $220,152 from RWJF for that “study.” She is a frequent RWJF grantee who often publishes journal articles with other  RWJF grantees.
*